Drug
Cetaphil
Cetaphil: highest development phase Post-Market, developed by Galderma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cetaphil NCT06357221 | Post-Market | Plaque Psoriasis |
Latest
No recent events.
Follow Cetaphil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.